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Abstract
Identification of early mechanisms that may lead from obesity towards complications such as metabolic syndrome is of
great interest. Here we performed lipidomic analyses of adipose tissue in twin pairs discordant for obesity but still
metabolically compensated. In parallel we studied more evolved states of obesity by investigating a separated set of
individuals considered to be morbidly obese. Despite lower dietary polyunsaturated fatty acid intake, the obese twin
individuals had increased proportions of palmitoleic and arachidonic acids in their adipose tissue, including increased levels
of ethanolamine plasmalogens containing arachidonic acid. Information gathered from these experimental groups was
used for molecular dynamics simulations of lipid bilayers combined with dependency network analysis of combined clinical,
lipidomics, and gene expression data. The simulations suggested that the observed lipid remodeling maintains the
biophysical properties of lipid membranes, at the price, however, of increasing their vulnerability to inflammation.
Conversely, in morbidly obese subjects, the proportion of plasmalogens containing arachidonic acid in the adipose tissue
was markedly decreased. We also show by in vitro Elovl6 knockdown that the lipid network regulating the observed
remodeling may be amenable to genetic modulation. Together, our novel approach suggests a physiological mechanism by
which adaptation of adipocyte membranes to adipose tissue expansion associates with positive energy balance, potentially
leading to higher vulnerability to inflammation in acquired obesity. Further studies will be needed to determine the cause of
this effect.
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Introduction
Obesity is characterized by excess body fat, which is
predominantly stored in the adipose tissue. Obesity is considered
one of the pathological features of metabolic syndrome (MetS),
which also includes insulin resistance, hypertension, and dyslipi-
demia [1]. Although not all obese individuals develop metabolic
and cardiovascular complications, the clustering of these condi-
tions of MetS suggests there may be pathogenic mechanisms
common to all these phenotypes [2,3].
The specific mechanisms that may lead from obesity towards
the higher risk of metabolic complications such as insulin
resistance and type 2 diabetes (T2D) remain elusive. Our preferred
nonexclusive hypothesis is the ‘‘adipose tissue expandability’’
PLoS Biology | www.plosbiology.org 1 June 2011 | Volume 9 | Issue 6 | e1000623hypothesis [2,4], which states that obesity-associated metabolic
complications such as insulin resistance are due to the finite
capacity of adipose tissue to expand and therefore to store energy.
In fact, once this limit of expansion is reached and the storage
capacity of adipose tissue is exceeded, the lipids become deposited
ectopically, leading to potentially toxic effects in peripheral tissues
via the excessive accumulation of reactive lipid species.
In support of the pathogenic role of limited adipose tissue
expandability and functionality we have previously shown in a
genetically obese leptin-deficient mouse (ob/ob) model that
ablation of adipogenic PPARc2 (the POKO mouse) leads to a
65% decrease in adipose tissue mass as compared to ob/ob mouse,
accumulation of reactive lipids in pancreatic islets, liver, and
muscle, and severe insulin resistance and diabetes [5]. Interest-
ingly, adipose tissue of the POKO mouse is also characterized by
an altered membrane phospholipid profile, characterized by
diminished levels of plasmalogens, the most abundant ether lipids
[5]. The opposite experimental paradigm, increasing the capacity
of adipose tissue expansion by overexpressing adiponectin in white
adipose tissue of ob/ob mice (the AdTG-ob/ob mouse), led to a
considerably improved metabolic profile as compared to ob/ob
mouse [6]. Based on this evidence we hypothesized that adaption
to the demands posed by positive-energy-balance-induced adipose
tissue expansion may challenge the homeostatic mechanisms
controlling phospholipid composition and their associated bio-
physical properties. However, given the importance of membrane
lipid composition and fluidity to maintain the topology, mobility,
or activity of membrane-bound proteins, and to ensure normal
cellular physiology, we also speculated that the process of adipose
tissue expansion should also incorporate allostatic adaptations
aiming to maintain membrane functionality for as long as possible
[7], particularly under metabolically challenging conditions. In
this respect we speculated that exhaustion of these allostatic
adaptations may determine the maximal limit of expansion and
may coincide with metabolic perturbations.
Investigations of adipose tissue ‘‘lipidome,’’ covering a global
profile of structurally and functionally diverse lipids, provide a
unique opportunity to pursue accurately and sensitively studies
profiling hundreds of molecular lipids in parallel [8]. The spatial
complexity of lipid metabolism presents a challenge for the study
of the global lipidomic profiles. Studies of lipidomic profiles in the
context of biochemical pathways may shed light on processes
behind the synthesis of or regulation by specific lipids, but cannot
address how these changes translate into lipid membrane
properties and affect cellular physiology. However, molecular
modeling tools and large scale computing capacities are becoming
available that facilitate modeling of lipid bilayers in the context of
their composition and function [9], thus opening new opportuni-
ties to interpret regulation and changes of global lipidome also in
the spatial and physiological context.
Given the recent increase in the prevalence of obesity and
MetS, it is clear that on top of their unquestionable polygenic
component, other environmental factors such as lack of physical
activity or high caloric diets are likely contributors to their
progressive acceleration. However, individual heterogeneity in
genetic and environmental profiles makes the search for specific
clues and mechanisms facilitating adipose tissue expansion and its
related metabolic complications in a general population a
daunting task. One suitable clinical study design setting to at least
homogenize and eliminate the genetic component of this challenge
is the twin design. Study of monozygotic (MZ) twin pairs,
discordant for body weight, provides an opportunity to explore
the initial effects of acquired obesity and related complications
since these individuals share not only an identical genetic
background at the DNA sequence level, but also early life events
and family environment. Identification of mechanisms behind the
traits related to acquired obesity and MetS is also relevant from
the therapeutic point of view, as these mechanisms may point to
targets for specific disease phenotypes that are not related to
specific genetic makeups.
To obtain a global view of human adipose tissue lipidome in
different degrees of acquired obesity, here we perform lipidomic
analyses of adipose tissue in twin pairs discordant for obesity but
still metabolically compensated. In parallel, we studied more
evolved states of obesity by investigating a separate set of morbidly
obese subjects. Information gathered from these experimental
groups was used for molecular dynamics (MD) simulations of lipid
bilayers using bioinformatics approaches, and the conclusions
were further supported by in vitro adipocyte confirmatory studies.
This approach uncovered the potential physiological mechanisms
by which adipocyte membranes adapt to adipose tissue expansion
associated with positive energy balance, ultimately leading to
obesity. Furthermore, we demonstrate how in extreme obesity,
failure of this adaptation is associated with the pathological
metabolic manifestation of obesity.
Results
Twin Study Design
We first investigated acquired obesity independent of genetic
influences in 13 MZ twin pairs discordant for body mass index
(BMI), and nine BMI-concordant MZ twin pairs, of which five
pairs were overweight (Table S1). The obese individuals were
young adults and were considered healthy obese, i.e., with no
clinical comorbidities, and thus in the early stages of the
Author Summary
Obesity is characterized by excess body fat, which is
predominantly stored in the adipose tissue. When adipose
tissue expands too much it stops storing lipid appropri-
ately. The excess lipid accumulates in organs such as
muscle, liver, and pancreas, causing metabolic disease. In
this study, we aim to identify factors that cause adipose
tissue to malfunction when it reaches its limit of
expansion. We performed lipidomic analyses of human
adipose tissue in twin pairs discordant for obesity—that is,
one of the twins was lean and one was obese—but still
metabolically healthy. We identified multiple changes in
membrane phospholipids. Using computer modeling, we
show that ‘‘lean’’ and ‘‘obese’’ membrane lipid composi-
tions have the same physical properties despite their
different compositions. We hypothesize that this repre-
sents allostasis—changes in lipid membrane composition
in obesity occur to protect the physical properties of the
membranes. However, protective changes cannot occur
without a cost, and accordingly we demonstrate that
switching to the ‘‘obese’’ lipid composition is associated
with higher levels of adipose tissue inflammation. In a
separate group of metabolically unhealthy obese individ-
uals we investigated how the processes that regulate the
‘‘lean’’ and ‘‘obese’’ lipid profiles are changed. To
determine how these lipid membrane changes are
regulated we constructed an in silico network model that
identified key control points and potential molecular
players. We validated this network by performing genetic
manipulations in cell models. Therapeutic targeting of this
network may open new opportunities for the prevention
or treatment of obesity-related metabolic complications.
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that obese individuals, as compared to their healthy lean twins,
already show signs of insulin resistance [10], exhibit a pro-
inflammatory serum lipidomic profile [11], have diminished
mitochondrial DNA copy number and dysregulated expression
of mitochondrial pathways such as branched chain amino acid
catabolism, and have elevated inflammatory and immune response
pathways in the adipose tissue [12].
Analysis of the weight-discordant twin pairs showed that the
obese twins were on average 15.2 kg (20%, 5.3 kg/m
2) heavier
than the non-obese twins and had more fat subcutaneously, intra-
abdominally, and in the liver (Table S1). Average adipocyte
diameter was 17% larger in the obese than in the non-obese twins,
and, interestingly, there was also a very high degree of intra-pair
similarity of fat cell size (FCS) (Figure S1). As expected,
adiponectin levels were lower, and leptin and hsCRP levels
higher, in the obese twins. The obese twins were also more insulin
resistant, as evidenced by the lower M-value and higher fasting
plasma glucose and serum insulin levels. Among the dietary intake
variables, the proportional intake of polyunsaturated fatty acids
(PUFAs) was 26% lower in heavy twins as compared to their lean
counterparts (p,0.05). The analysis of weight-concordant twin
pairs showed no intra-pair differences in FCS, adipokines, or
insulin sensitivity (Table S1).
Adipose Tissue Lipidome in Acquired Obesity
To characterize the adipose tissue lipidome in acquired obesity,
we applied the global lipidomics approach using ultra performance
liquid chromatography coupled to mass spectrometry (UPLC-MS).
The analysis was performed in positive ion mode (ESI+), which is
sensitive to neutral lipids (such as triacylglycerols) and major
phospholipid classes such as phosphatidylcholines (PCs), phospha-
tidylethanolamines (PEs), and sphingomyelins. A total of 313 lipids
were detected and quantified in each of the 44 samples analyzed.
Additionally, free cholesterol was determined by gas chromatogra-
phy coupled to mass spectrometry (GC-MS), and the data were
included inthelipidomicdataset.Sinceweconsidered that adipocyte
sizemightbea factoraffecting membrane and celllipid composition,
we investigated the lipidome redistribution in relation to the cell size.
Thus, following the calibration with internal standards we further
normalizedthe databythetotalamountof detected phospholipidsin
each sample. This allowed us to investigate the relative composi-
tional changes of adipose tissue lipids.
When comparing the weight-discordant twins, lipidomic
analysis revealed characteristic differences in cellular phospholip-
ids (Figure 1A). The dominating characteristic of adipose tissue in
the obese twins was the elevation of PUFA-containing phospho-
lipids, which were predominantly ether lipids, and proportional
diminishment of phospholipids containing shorter and more
saturated fatty acids. These lipids were clustered according to
BMI in both the discordant and concordant twin pairs, suggesting
that these observed changes are characteristic of adipose tissue
expansion per se, irrespective of genetic makeup. Figure 1B further
illustrates this by showing the normalized concentrations of the
most abundant significantly altered lipids. The most abundant
PUFA-containing ether lipids were confirmed to be plasmalogens
(Figure S2). Partial least squares regression of lipidomic data
related to FCS showed that the changes in the top-ranking lipids
associate with the increase of adipocyte cell size in obesity (Figure
S3). In line with this, triacylglycerols were also elevated in the
adipose tissue of obese twins at the marginal significance level false
discovery rate (FDR) q,0.1 (Figure S4). Free cholesterol in
adipose tissue did not differ significantly between the obese and
lean twins (Figure S5).
Acquired Obesity Leads to Selectively Enhanced Fatty
Acid Desaturation and Elongation in Adipose Tissue
The observed changes in phospholipids in acquired obesity
appear to be highly selective, showing both functional group as
well as fatty acid specificity. It is known that PUFAs are selectively
targeted to plasmalogens [13,14], which could explain enrichment
of adipose tissue ether lipids in acquired obesity (Figure 1).
Notably, among the elevated plasmalogens observed in the obese
individuals, the fatty acid dominantly esterified in the sn-2 position
is arachidonic acid and not docosahexanoic acid (DHA), which is
also commonly found in plasmalogens [13].
To investigate whether specific global fatty acid compositional
changes occur in the adipose tissue in response to weight gain, we
analyzed fatty acid profiles in weight-discordant twin pairs. We
found marked differences in several fatty acids (Table S2), which
included diminishment of stearic (C18:0), linoleic (C18:2n6), and
a-linolenic (C18:3n3) acids and elevation of palmitoleic (C16:1n7)
and arachidonic (C20:4n6) acids (Figure 2A). In relation to known
dietary intake, the data are consistent with diminished PUFA
intake (decreased linoleic and a-linolenic acids), while other
changes appear to reflect an induced specific program of fatty acid
desaturation and elongation (Figure 2B), which leads to elevated
palmitoleic acid via desaturation of palmitic acid, and to elevated
long-chain PUFAs up to arachidonic acid, but not to DHA. The
specific changes in PUFA composition are consistent with the
observed changes in phospholipids. However, the elevation of
esterified palmitoleic acid in the adipose tissue of the obese twins
was not reflected in significantly elevated free palmitoleate levels in
serum (Table S3 and Figure S6).
Elevated PUFA-Containing Phospholipids Help Maintain
Membrane Fluidity and Thickness
The observed remodeling of membrane phospholipids in
expanding adipocytes of obese twins suggests that these changes
may also have an effect on membrane properties such as
membrane fluidity (packing), order, and thickness, which are
known to affect cellular physiology [15,16]. There is evidence from
in vitro model systems and from atomic-scale MD simulations of
lipid bilayers that an increase in PUFA content will increase
membrane fluidity [17–19]. The lateral diffusion of lipids [20] and
the permeability of the membrane to small molecules [21] are
dependent on the fluidity through packing and degree of order in
the bilayer. However, the effect of the vinyl-ether bond in
plasmalogens on membrane fluidity is poorly understood and has
not yet been modeled using MD simulations.
To study the consequences of altered lipidomic profiles on
membrane biophysical properties, we performed atomic-scale MD
simulations of eight different membrane systems. Based on
measured abundance of differentially regulated lipids (Figure 1),
the following lipid types were used in simulations: PC(16:1/18:0),
PC(P-16:1/18:0), PC(16:0/20:4), PC(P-16:0/20:4), PE(16:0/20:4),
and PE(P-16:0/20:4). Structures of PC(16:0/20:4) and PC(P-16:0/
20:4) are shown in Figure 3A. In addition to six one-component
bilayers composed of these lipids individually, we also studied two
additional mixtures of PC(16:1/18:0) and PE(P-16:0/20:4) with
PE concentration of 59 mole percent (low BMI mix) and 70 mole
percent (high BMI mix). The mixtures were designed to mimic the
compositional difference between the obese and non-obese twins
(Figure 1B). The selection of the specific six lipid molecules was
motivated by the need to characterize specific effects due to three
different types of structural changes observed in the lipids: (1)
functional group (PE versus PC), (2) vinyl-ether versus ester bond
in sn-1 position, and (3) degree of saturation in the sn-2 chain.
Remodeling of Adipose Tissue Lipidome
PLoS Biology | www.plosbiology.org 3 June 2011 | Volume 9 | Issue 6 | e1000623Figure 1. Adipose tissue lipidome in acquired obesity. Lipidomic analysis covered 314 molecular lipids in adipose tissue biopsies from 44
subjects (13 twin pairs discordant for BMI, nine twin pairs concordant for BMI). Thirty-four lipids were differentially regulated when comparing obese
and lean weight-discordant twins (FDR q,0.05). (A) Lipidomic profiles of the 34 differentially regulated lipids in acquired obesity, shown for all
subjects included in the study. The detected ether phospholipids are marked in green. The twin status for each subject is shown at the bottom. (B)
Concentration, shown as fraction of the total phospholipid concentration as measured by lipidomics (Tot. PL), of the 11 most abundant differentially
regulated lipids from (A), shown separately across the four groups corresponding to lean and heavy twins discordant for BMI, and the concordant
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combinations in membranes is not feasible because of the major
computational cost. Therefore, the above choice of the eight
model systems aims to clarify the overall effects on membrane
fluidity arising from the three different structural changes observed
in lipids, but with a reasonable cost. Yet the total simulation time is
major, about 1 ms.
Figure 3B displays the average surface area per lipid, describing
the overall packing of the lipids within the membrane plane. The
larger the area per lipid, the more fluid the membrane is.
Figure 3C shows that when plasmalogens are replaced with the
corresponding ester lipids, the area per lipid increases by about
0.01–0.02 nm
2. An increase of 0.07–0.09 nm
2 is found when PE is
replaced by PC headgroup. Finally, increasing the unsaturation of
PC acyl chains increases the average surface area per lipid by
0.02–0.03 nm
2. Together, membrane fluidity is promoted by
decreasing plasmalogen concentration, using PC instead of PE
headgroup, and increasing PUFA content. The snapshots in
Figure 3D illustrate different packings and thus different degrees of
fluidity in four of the studied bilayers.
As expected, membrane thickness is negatively correlated with
area for all studied systems. Furthermore, increased lateral packing
correlates with a higher conformational order of the acyl chains.
To illustrate this point, Figure 3C shows the inverse of molecular
order parameter (Smol) averaged over the saturated segments of the
sn-1 acyl chains. It is clear that the sn-1 chains of plasmalogens are
more ordered than the corresponding chains in the ester-bonded
lipids.
To our surprise, no marked differences in the surface area and
thus fluidity are observed when high and low BMI lipid mixtures
are compared (Figure 3B). The data therefore suggest that the
increased fluidity due to elevated PUFA content in membrane
phospholipids is compensated for by decreased fluidity of the
elevated PE plasmalogen lipids, with the final result that there is no
change in membrane fluidity and thickness. The membrane
clearly has compensatory mechanisms to maintain its fluid nature.
Adipose Tissue Network
Next, we investigated the regulatory mechanisms that may
be behind the observed lipid remodeling. Because of the
intrinsic complexity of lipid metabolism, interactions of
multiple components are likely involved in the regulation of
lipid changes [22]. To capture such functional interconnec-
tions between the biological entities, we considered a network-
based approach to be more suitable than studies of differential
expression changes at the individual gene level. We selected
ten clinical variables, 31 lipid-metabolism-related genes from
the published dataset [12] obtained from the same samples
used in the present study, two pathway profiles reflecting major
changes observed in pathway analysis [12], and ten lipid
variables representative of major changes observed in adipose
tissue lipid profiles (Table S4). As the only ‘‘input’’ variable, we
used dietary PUFA intake (PUFA percent). To distinguish
direct and indirect interactions of these variables, we utilized
the QPGRAPH method, which has been previously applied to
study gene regulatory networks based on microarray data [23].
The key idea of QPGRAPH is to use partial correlations as a
measure of dependency and build an undirected Gaussian
graphical model where the variables are connected if and only
if their partial correlation is significantly non-zero. Unlike the
pairwise measure of associations, e.g., Pearson correlation
coefficients, partial correlation provides a stronger criterion for
dependency by adjusting for confounding effects, and thus
removes spurious associations to a large extent. This is
particularly favorable for such an integration of multiple
layers of information, as it inherently filters out false positives
by discovering only those direct interactions with high
confidence.
The data-driven dependency network in twins discordant for
obesity is shown in Figure 4. Notably, PUFA percent was
connected to CD36, an important fatty acid transporter [24],
which was further connected to fatty acid elongase Elovl6. In
such a network context, identification of genes connected to
many other genes or variables of interest, i.e., so-called network
hubs, is of particular interest. For example, despite not being
differentially regulated itself, Elovl6 appears to be an important
hub, with seven connections, including desaturase SCD1. Among
the other important regulators of lipogenesis, PPARc was
significantly down-regulated in obese twins, and, along with fatty
acid elongase Elovl4, which was not differentially regulated, was
associated with the decreased fatty acid ratio of C22:5 versus
C20:5, a step which appears to affect the balance between the
amounts of arachidonic acid and DHA (Figure 2). In agreement
with earlier findings [25], the decreased expression of PPARc was
also associated with decreased expression levels of insulin receptor
substrate 2 (IRS2).
Elovl6 Regulates the Membrane Phospholipid
Remodeling in Adipose Tissue
We then investigated whether the observed network might be
amenable to modulation of the lipid profiles observed in the
weight-discordant twins. Given its position as a network hub
(Figure 5) and its known regulatory role in the control of
cellular fatty acid composition [26], we hypothesized that
ablation of Elovl6 might be an upstream regulator of the lipid
remodeling observed in obese twins, sensitive to dietary
stimulus such as relative decrease in PUFA intake. To gain
further insights we hypothesized that ablation of Elovl6 in the
3T3-L1 adipocyte cell line might reveal a mirroring lipid
pattern. In fact, lipidomic analysis of preadipocytes and mature
adipocytes revealed that ablation of Elovl6 leads to a lipid
profile opposite to the one observed in obese twins, thus
supporting our model (Figure 5 and Table S5). Specifically,
knock-down of Elovl6 leads to a reduction in PUFA-containing
phospholipids, which are predominantly ether-bonded, and to a
proportional elevation of shorter and more saturated phospho-
lipid species.
Membrane Lipid Remodeling Breaks Down in Morbid
Obesity
To investigate the lipid profile in pathogenic stages of obesity,
we compared the adipose tissue lipid compositional changes in
obesity-discordant twin pairs (Figure 1B) with lipidomic profiles
from our recent study of eight morbidly obese subjects recruited
among patients undergoing laparoscopic surgery for the treatment
of obesity [27]. The BMI range was 47.0–60.4 kg/m
2; four
subjects had elevated fasting serum insulin (.10 mU/l), and
among these two subjects were diagnosed with T2D. The levels of
shorter and more saturated phospholipids were similar in the
twin pairs divided into two groups: high BMI (BMI$25 kg/m
2) and low BMI (BMI,25 kg/m
2). p-Values are shown for pairwise t test comparison of
discordant twins. *, p,0.05; **, p,0.01; ***, p,0.001. Error bars are 6 SEM. SM, sphingomyelin.
doi:10.1371/journal.pbio.1000623.g001
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However, the proportion of PUFA-containing ether lipids was
markedly lower (Figure 6B), indicating that the mechanism of lipid
remodeling observed in healthy obese subjects had broken down
or that it was unable to compensate at that level of stress. In
contrast to the obese twins, the linear dependence of fasting serum
insulin on FCS appears to have broken down in the morbidly
obese subjects (Figure 6C and 6D). The major outliers were the
two subjects diagnosed with T2D, who had the smallest FCS and
the highest fasting serum insulin concentrations (Figure 6D).
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Figure 2. Fatty acid composition of adipose tissue in acquired obesity. Fatty acid profile was measured in adipose tissue biopsies in each of
the 44 subjects. Complete results are shown in Table S2. (A) Selected fatty acid relative amounts in 13 twin pairs discordant for BMI. Lines connect the
pairs of twins. (B) Schematic representation of fatty acid compositional changes when comparing heavy and lean obesity-discordant twins. Significant
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PLoS Biology | www.plosbiology.org 6 June 2011 | Volume 9 | Issue 6 | e1000623Figure 3. Large-scale molecular dynamics simulations of different lipid membrane systems. Six single-lipid component systems were
studied, representing major groups of lipids found to be differentially regulated in acquired obesity (Figure 1A). Two lipid mixes, corresponding to
observed concentration changes of most abundant lipids (Figure 1B), were also studied to represent lipid membrane composition in heavy and lean
weight-discordant twins. (A) Structures of two PUFA-containing PCs included in the simulations, one plasmalogen and one ester-bonded. (B) Average
area per lipid of the eight simulated bilayer systems, indicating the packing or fluidity of the bilayer (smaller area means decreased fluidity). (C) The
molecular order parameter (Smol) profiles along selected unsaturated acyl chains. Segment number means the carbon position starting from ester-
vinyl linkage and ending at the methyl group in the end of the chain. (D) Snapshots from the end of four simulations, with the lipids ordered from top
to bottom according to decreased fluidity (area per lipid parameter from [B]).
doi:10.1371/journal.pbio.1000623.g003
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Adipose tissue is a highly active endocrinometabolic organ
whose main role is to provide efficient storage and mobilization of
lipids to fulfill bioenergetic demands. Adipocyte function depends
on the homeostasis of important cellular lipid mediators and lipid
structural components of biological membranes required for
accurate functional responses. These lipid functions are intercon-
nected, e.g., the membrane lipids also serve as precursors of lipid
mediators. Modern lipidomics technologies enable characteriza-
tion of cellular lipidomes across multiple structural and functional
groups. However, the analysis and interpretation of data from such
datasets are commonly limited to the level of biochemical and
signaling pathways. In this study, we presented a new approach to
study global lipidomes in tissues and cells by combining cellular
lipid networks with lipid membrane modeling. This strategy
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Figure 4. Regulation of lipid remodeling in adipose tissue. A dependency network was constructed from selected gene expression, clinical,
and lipidomic data from twin pairs discordant for BMI. Node shapes represent different types of variables and platforms (L, UPLC-MS lipidomics; FA,
fatty acid gas chromatography; GE, gene expression), node color corresponds to significance and direction of regulation (full data in Table S4), and
line width is proportional to strength of dependency. The variables are connected by an edge if and only if their partial correlation is significantly
non-zero. PUFA percent and the nearest network hub (Elovl6) are highlighted with green squares. The cutoff for the presence of edge was set at 0.55
by the average non-rejection rate, i.e., an edge in the graph tested positive in 55% of the 500 samplings.
doi:10.1371/journal.pbio.1000623.g004
Remodeling of Adipose Tissue Lipidome
PLoS Biology | www.plosbiology.org 8 June 2011 | Volume 9 | Issue 6 | e1000623enabled us to identify adaptive mechanisms that may lay behind
the characteristic remodeling of the adipose tissue lipidome in
response to positive-energy-balance-induced adipose tissue expan-
sion during the evolution of obesity.
There is evidence suggesting that the total number of adipocytes
in humans tends to remain constant during a lifetime [28] under
physiological conditions. Consequently the excess lipid load in
acquired obesity poses an extra layer of stress on the adipose tissue,
which can be compensated by increasing the size of the adipocytes
and/or overstimulating the normal processes of adipocyte
turnover in the adipose tissue. This relative stability of the adipose
tissue cellular composition requires active regulatory mechanisms.
Figure 5. Regulation of lipidomic profiles by Elovl6 in differentiated adipocytes. 3T3-L1 preadipocytes were differentiated in wild-type
(control) cell line, and following 50% and 70% Elovl6 knockdown (KD) (three biological replicates for each group). Lipidomic analysis was performed
in preadipocytes and in mature adipocytes. One-way ANOVA was performed to test for the significance of time (mature adipocytes versus
preadipocytes) and group-specific lipid changes. Error bars are 6 SEM. Tot. PL, total phospholipids as measured by lipidomics. (A) The upregulated
phospholipids in Elovl6 knockdown cells are mainly shorter chain and saturated. Selected lipids are shown. (B) The diminished phospholipids are
mainly PUFA containing, predominantly ether lipids. Selected lipids are shown. All differentially regulated phospholipids in Elovl6 knockdown cells
are listed in Table S5.
doi:10.1371/journal.pbio.1000623.g005
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increased in obese individuals relative to their lean twins in weight-
discordant MZ twin pairs (Figures 6C and S1). We also observed a
high degree of intra-pair similarity of FCS in weight-concordant
MZ twin pairs (Figure S1), which suggests a strong genetic
component tightly regulating FCS. These changes in cell size may
lead to and/or be affected by minor variations in membrane
composition, resulting in changes in membrane fluidity and lateral
pressure [9]. It would be expected that these changes would
consequently affect the membrane protein function and thus
cellular physiology. In this context we consider adipose tissue
expansion in response to positive energy balance to be a challenge
for the maintenance of membrane integrity and function,
requiring potent adaptive allostatic responses.
With adipose cell expansion, more phospholipids have to be
incorporated into the cellular membranes. However, this process
also requires a very accurate quality control system that ensures
that irrespective of the available lipid pool, the composition of the
membrane and its functionality is appropriate in expanding
adipocytes and newly recruited adipocytes. We found that the
expansion of adipose tissue is accompanied by a proportional
increase of PUFA-containing ether lipids and a decrease of more
saturated and shorter-chain ester-bound lipids (Figure 1). These
changes were also reflected in the altered fatty acid composition
(Figure 2). Given that no increase was observed in saturated short-
chain fatty acids (Figure 2), it is unlikely that de novo fatty acid
synthesis could explain the observed fatty acid profile. Of interest,
proportional dietary intake of PUFA was lower in obese twins than
in their lean counterparts, and this was reflected in the diminished
linoleic and a-linolenic acids (Figure 2). However, paradoxically,
the concentration of arachidonic acid was increased in the obese
twins, as was also reflected in the altered profile of the
phospholipids. Notably, this increase was specific to arachidonic
acid since there was no difference between the levels of DHA of
the obese and lean twins (Figure 2). The observed lipid changes are
not systemic since we have previously shown that the ether lipids
are down-regulated in the serum of the obese twins [11].
Our findings support the view that positive energy balance
leading to obesity initiatesa program of membrane lipid remodeling
in the adipose tissue, involving increased biosynthesis of unsaturated
fatty acids including arachidonic acid (Figure 7). In agreement with
earlier findings [29–31], arachidonic acid is actively incorporated
into the membrane phospholipids and selectively targeted to
ethanolamine plasmalogens (Figure 1). However, if the only
membrane compositional changes were these specific changes in
the fatty acid composition, the membrane would become more fluid
[19]. Instead, our membrane simulations showed that the targeting
of PUFAs to ether lipids, and preferentially to the most abundant
ethanolamine plasmalogen, helps to maintain membrane biophys-
ical properties. In fact, it is known that a relative increase in the PE/
PC ratio contributes to increasing the rigidity of the membrane [32]
and therefore compensating for increased fluidity mediated by
unsaturated fatty acids. Here we also provided evidence based on
biophysical modeling that supports the view that the presence of a
vinyl-ether bond in the sn-1 position of phospholipids contributes to
further stiffening of the membrane.
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Figure 6. Adipose tissue in morbid obesity is characterized by diminished levels of PUFA-containing ether lipids. Comparison of the
amounts of abundant phospholipids differentially regulated in acquired obesity in the subcutaneous adipose tissue (Figure 1B), shown as a fraction
of the total phospholipid concentration, with the mean amounts in intra-abdominal (Ia fat) and subcutaneous (Sc fat) tissue biopsies of eight
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abundant shorter-chain and saturated phospholipids. *, p,0.05; **, p,0.01. (B) The most abundant ether phospholipids are markedly diminished in
morbid obesity. (C) FCS and fasting serum insulin (fS-Insulin) in morbidly obese subjects and twins discordant for obesity. (D) FCS correlates with
fasting serum insulin in twins (all 44 subjects included in the study), but not in morbidly obese subjects. The two subjects diagnosed with T2D are
marked with filled circles.
doi:10.1371/journal.pbio.1000623.g006
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carry a price. In fact, plasmalogens can serve as antioxidants
against reactive oxygen species and might thus protect the cells
from oxidative stress [33,34]. However, when arachidonic-acid-
containing plasmalogens are under oxidative stress, they become
precursors of arachidonic-derived lipid mediators such as
leukotrienes and hydroxyeicosatetraenoic acids [29,31,35,36].
These reactive lipids are important mediators of inflammatory
response [37]. Thus, this remodeling process occurring in the
membranes may make the adipocytes more vulnerable and prone
to inflammatory responses (Figure 7), in agreement with the
elevation of inflammatory pathways in the obese twins of weight-
discordant twin pairs [12]. In the context of inflammation, a
crucial step in the observed lipid remodeling is the relative
decrease of C22:6 (DHA) and C22:5 as compared to C20:5,
leading to a relative increase of arachidonic acid content relative to
DHA in acquired obesity (Figure 2). In contrast to arachidonic-
acid-derived lipid mediators, the DHA-derived lipid mediators
tend to have anti-inflammatory properties [38]. We propose that
stimulation of fatty acid elongation from C20:5 to C22:5 and
desaturation from C22:5 to C22:6 could be one strategy to
maintain the membrane function in acquired obesity, while also
avoiding the collateral damage of increasing the vulnerability of
adipose tissue to inflammation.
We observed a high degree of linearity in FCS variation in
weight-discordant twin pairs (Figure S1). This suggests that
adipocytes of these relatively modestly obese twins are still within
the range of normal expansion and meeting the demands imposed
by their specific nutritional demands. However, this physiological
process appears to be disrupted in states of excessive adipose
expansion beyond homeostatic capacity in morbidly obese
subjects, characterized by decreased concentrations of ethanol-
amine plasmalogens compared to the ‘‘healthy obese’’ twins
(Figure 6B). In morbidly obese individuals, fasting serum insulin
does not correlate with FCS (Figure 6D). The two diabetic subjects
in this group had, in fact, the smallest FCS, indicating that the
limit of adipocyte expandability may have been reached.
Identification of pathways involved in regulation of early
adaptation to excess lipid load is important, since these pathways
might provide clues about prediction, prevention, or treatment of
obesity-related metabolic complications.
We used the network approach, rather than a simpler gene
expression level analysis, to determine critical nodes that could
control adipose tissue lipidome remodeling. Doing so, we detected
Elovl6, which, while not changed on an mRNA expression level
itself, appeared to be connected to multiple different factors
involved in controlling adipose tissue lipidome (Figure 4). To
validate that perturbations in Elovl6 function were capable of
mediating at least some of the changes observed in the obese twins,
we used a cell line to validate our network. Consistent with our
hypothesis,knockdownofElovl6in3T3-L1adipocytesmirroredthe
results found in the obese twins, therefore suggesting that the
observed lipid remodeling may be amenable to genetic modulation.
As a potential limitation of the study, lipidomic analysis was
performed in adipose tissue biopsies and not in isolated adipocytes.
It is known that obesity is associated with the infiltration of
inflammatory cells in the adipose tissue [39,40]. We have in fact
observed elevation of multiple inflammatory and immune
pathways in the obese twins in our sample [12]. However,
adipocytes and their lipids constitute most of the adipose tissue
pool per unit volume, and it is therefore unlikely that the observed
large change in phospholipid composition is due to changes in
percent cellular composition of the adipose tissue. Furthermore, if
that were the case, the lipidome changes observed in morbidly
obese subjects (Figure 6) would have followed the same trend, but
to an even greater extent, as observed in the obese twins.
One of the advantages of the twin study setting in the context of
understanding human obesity is the possibility to explore the initial
effects of acquired obesity and related complications independent
of genetic makeup. The weight differences between the twins in
the discordant pairs began to emerge at 18 y of age [41], and diet
appears to be the major factor behind these differences [42]. The
discordant pairs were of the same age (mean 6 standard deviation
=25.661.2 y) as the concordant pairs (25.761.2 y); therefore, age
cannot be considered a confounding factor in our study. The fact
that it was extremely challenging to find even this number of MZ
twin pairs discordant for weight (only 14 pairs out of the cohort of
2,453 twins born in Finland in the years 1975–1979, among which
adipose tissue was available from 13 pairs) and the fact that the
obesity phenotypes found were within a narrow range, suggest a
strong genetic and early environmental basis for susceptibility to
obesity. Therefore, our study design offers considerable advantag-
es over other types of studies in humans where groups with
different obesity phenotypes also differ for their genotypes.
In summary, we have used a novel approach to study cellular
lipidomes, and our study proposes an allostatic mechanism by
Figure 7. Model of physiological regulation of lipid membrane composition in obesity. MUFA, monounsaturated fatty acid; PL,
phospholipid; SFA, saturated fatty acid.
doi:10.1371/journal.pbio.1000623.g007
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adipose tissue at the expense of increasing its vulnerability to
inflammation. The lipid remodeling seems to be triggered by the
proportional decrease of PUFA content and is controlled by a
complex network involving fatty acid desaturation and elongation.
If small molecules could modulate this network for both
membrane functional maintenance and vulnerability to inflam-
mation, new opportunities may arise for the prevention or
treatment of obesity-related metabolic complications.
Materials and Methods
Subjects and Twin Study Design
Twin pairs included in the current study were recruited from a
population-based longitudinal study of five consecutive birth
cohorts in Finland (1975–1979) of twins (n=2,453) [43], based
on their responses to questions on weight and height at age 23–27
y. From this cohort, we searched for the top 5% most obesity-
discordant MZ twin pairs (one twin non-obese [BMI ,25 kg/m
2]
and the other one obese [BMI ,30 kg/m
2]), with no significant
height differences (,3 cm). After screening all MZ twin pairs
(n=658), we identified 18 pairs above the 95
th percentile of BMI
differences (3.1 kg/m
2) [10,41,44–47]. Fourteen of these pairs
(eight male and six female pairs) were willing to participate, and
thirteen pairs (eight male and five female pairs; BMI differences
3.3–10.0 kg/m
2) had adipose tissue samples available for the
present study. We also studied nine randomly selected weight-
concordant MZ pairs (two male and three female overweight pairs
and two male and two female normal-weight pairs, BMI
differences 0.0–2.3 kg/m
2). All pairs were Caucasian, and the
discordant pairs were of the same age (mean 6 standard deviation
25.661.2 y) as the concordant pairs (25.761.2 y). The subjects
were healthy (based on medical history, clinical examination, and
structured psychiatric interview), normotensive, and did not use
any medications except contraceptives. Their weight had been
stable for at least 3 mo prior to the study. Females were scheduled
to attend during the follicular phase of their menstrual cycle.
Monozygosity was confirmed by the genotyping of ten informative
genetic markers [41]. Dietary information was collected based on
3-d food diary as described previously [10]. Further details on
experimental methods are provided in Text S1.
The subjects provided written informed consent. A small
amount of subcutaneous fat tissue aspirated by needle biopsy
was used for the metabolic studies of adipose tissue, as described in
the consent form. The protocol was designed and performed
according to the principles of the Helsinki Declaration and was
approved by the Ethical Committee of the Helsinki University
Central Hospital.
Culture, Differentiation, and Infection of 3T3-L1
Preadipocytes
3T3-L1 cells were cultured, and differentiated into adipocytes
using the following protocol. 3T3-L1 preadipocytes were passaged
in 25 mM glucose DMEM supplemented with 1% Pen-Strep
(Sigma Aldrich P0781) and 1% glutamine (Sigma Aldrich G7513).
Differentiation cells were plated into six-well culture dishes and
allowed to grow to confluence. Two days post confluence 3T3-L1
preadipocytes were induced to become adipocytes. The induction
medium was 25 mM DMEM with 10% fetal bovine serum (Sigma
Aldrich), 1% L-glutamine, and 1% Pen-Strep (FBS medium)
supplemented with 100 nM insulin, 1 mM dexamethasone, and
0.5 mM IBMX. At day 2 the medium was replaced with FBS
medium with insulin alone. From day 4 until day 8 cells were
grown in FBS medium alone until adipogenesis was complete.
Differentiated cells were used only when at least 95% of the cells
showed an adipocyte phenotype by accumulation of lipid droplets
by day 8. Cells were analyzed by phase contrast microscopy.
Elovl6 knockdown cells (or controls) were generated with the
pSiren-RetroQ retroviral vector system. All retrovirally transfected
3T3-L1 cell lines were kept in puromycin-containing medium
throughout culture and differentiation procedures.
Retroviral Short Hairpin RNA Constructs for Elovl6
Stable knockdown of Elovl6 was achieved by expression of short
hairpin RNA from the pSiren-RetroQ vector (Clontech). Target
sequences for knockdown of Elovl6 (GenBank Accession number
NM_130450) were identified using the Dharmacon siDesign
center, and control cells were infected with virus for a scrambled
short hairpin RNA. Custom oligonucleotides (sequences available
on request) were designed to incorporate these sequences into
short hairpin RNA expression sequence, and cloned into pSiren-
RetroQ according to the manufacturer’s instructions. The
knockdown was confirmed at mRNA and enzyme activity levels
(Figure S7) using the methods described in Text S2.
Lipidomic Analysis of Adipose Tissue and 3T3-L1
Adipocytes
Global lipidomic profiles of adipose tissue biopsies were
determined by using a UPLC-MS platform [48]. Data processing
was performed using the MZmine software [49,50]. Slightly
different analytical methods were applied for the tissue biopsies
and 3T3-T1 adipocytes (Text S3). Serum-free fatty acids as well as
adipose tissue esterified fatty acids were measured by gas
chromatography. Free cholesterol in adipose tissue biopsies was
determined using GC-MS. Further details on lipidomic analysis
are provided in Text S3.
Statistical Methods
Statistical analyses were performed using the freely available R
statistical software (http://www.r-project.org). FDR q-values [51]
were computed using statistical methods from R package
‘‘qvalue.’’ Chemometric modeling using partial least squares
[52] regression was performed using Matlab version 7.0 (Math-
works) and PLS Toolbox version 4.0 of the Matlab package
(Eigenvector Research). The model-based clustering was per-
formed using the MCLUST method [53], implemented in R (Text
S4). Construction of the adipose tissue network for selected
variables was performed using undirected Gaussian graphical
Markov networks that represent q-order partial correlations
between variables, implemented in the R package ‘‘qpgraph’’
[23] that forms part of the Bioconductor project (http://www.
bioconductor.org). In these networks, missing edges denote zero
partial correlations between pairs of variables, and thus imply the
conditional independence relationships in the Gaussian case (Text
S4). The network was visualized using Cytoscape [54] and yED
graphical editor [55].
Lipid Bilayer Simulations
All simulated bilayer systems consisted of 128 lipid molecules and
about 3,500 water molecules. The initial structures of all bilayers
were obtained by modification of a dipalmitoylphosphatidylcholine
(DLPC) bilayer simulated for 130 ns as described in our previous
study [56]. All the simulations were performed using GROMACS
software package version 4.0.4 [57] over a time scale of 100 ns. The
first 40 ns were considered an equilibration period, and the
remaining period of 60 ns of each trajectory was analyzed. Further
detail on experimental methods is provided in Text S4.
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Figure S1 Fat cell size in twins discordant and concor-
dant for obesity.
Found at: doi:10.1371/journal.pbio.1000623.s001 (0.06 MB PDF)
Figure S2 ESI+ tandem mass spectrometry spectra of
plasmalogens. The plasmalogen identification using tandem
mass spectrometry is based on characteristic peaks acquired in
positive ion mode.
Found at: doi:10.1371/journal.pbio.1000623.s002 (0.03 MB PDF)
Figure S3 Fat cell size in acquired obesity correlates
with changes in phospholipid profile. Partial least squares
regression of 34 differentially regulated lipids (Figure 1A) on FCS.
Each lipid and FCS variable X was twin-normalized using the
formula Xnorm=log2(Xheavy/Xlean), where Xheavy is the variable X
value for the heavy twin and Xlean is the variable X value for the
lean twin.
Found at: doi:10.1371/journal.pbio.1000623.s003 (0.01 MB PDF)
Figure S4 Most abundant triacylglycerols in adipose
tissue, sorted according to abundance in the lean twins
of weight-discordant pairs. When comparing obesity-discor-
dant twin pairs (heavy versus lean twin) using pairwise t test, none
of the shown triglycerides reached FDR q,0.05, but they were all
marginally significant at FDR q,0.1. Error bars are 6 standard
error of the mean (SEM). Tot. PL, total phospholipids as measured
by lipidomics.
Found at: doi:10.1371/journal.pbio.1000623.s004 (0.07 MB PDF)
Figure S5 Free cholesterol in adipose tissue. None of the
comparisons are statistically significant. Error bars are 6 SEM.
Found at: doi:10.1371/journal.pbio.1000623.s005 (0.02 MB PDF)
Figure S6 Serum palmitoleate correlation with adipose
tissue esterified palmitoleate. Twin normalization was
performed as described in Figure S3.
Found at: doi:10.1371/journal.pbio.1000623.s006 (0.03 MB PDF)
Figure S7 Elovl6 enzyme activity and mRNA expression
in 3T3-L1 cell lines. (A) Elovl6 3T3-L1 knockdown cell lines
have a functional reduction in C16:0–C18:0 fatty acid elongation
ability. Elongation activity expressed as incorporation of radioac-
tive malonyl-CoA into lipid fraction in picomoles per milligram of
protein of isolated microsomes per minute. Palmitoyl-CoA was
used as the substrate for elongation in the reaction. (B) Degree of
knockdown of Elovl6 mRNA in 3T3-L1 cell lines. Expression in
arbitrary units normalized to 18s housekeeping gene. *, p,0.05
versus control line, Student’s t test followed by Bonferroni
correction for multiple tests; n=3 replicates per group.
Found at: doi:10.1371/journal.pbio.1000623.s007 (0.04 MB PDF)
Table S1 Physical and biochemical characteristics of
weight-discordant (n=13) and weight-concordant (n=9)
monozygotic twin pairs. Data are median (interquartile
range).
aObese versus non-obese twins, paired Wilcoxon’s test.
bn=9 discordant pairs.
Found at: doi:10.1371/journal.pbio.1000623.s008 (0.04 MB
DOC)
Table S2 Fatty acid composition in adipose tissue lipids
of weight-discordant (n=13) and weight-concordant
(n=9) monozygotic twin pairs. Data are median (interquar-
tile range) (in molar precentage).
aObese versus non-obese twins,
paired t test.
Found at: doi:10.1371/journal.pbio.1000623.s009 (0.04 MB
DOC)
Table S3 Serum-free fatty acid composition in adipose
tissue lipids of weight-discordant (n=13) and weight-
concordant (n=9) monozygotic twin pairs. Data are
median (interquartile range) (in mmol/l).
aObese versus non-obese
twins, paired t test.
Found at: doi:10.1371/journal.pbio.1000623.s010 (0.04 MB
DOC)
Table S4 Selected variables included in the dependency
network analysis.
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differentiating mature adipocytes in Elovl6 70% knock-
down cell line as compared to controls.
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